4 completed, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow COP protocol 2: new trials by email Literature Review of COP protocol 2 trials Research Report on COP protocol 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanubrutinib Combined With G-CVP in Previously Untreated FL zanubrutinib, obinutuzumab,combined with CVP - Follicular Lymphoma ( FL) | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 40 | 2025-01-01 | 2025-05-07 |
| Association of Intraoperative Haemodynamic and Postoperative Complications in Type A Aortic Dissection Surgery Primary exposures were venous congestion defined by central venous pressure (CVP) and mean arterial pressure (MAP). - Acute Kidney Injury | Completed | Nanjing First Hospital, Nanjing Medical University | 543 | 2023-10-01 | 2024-06-03 | |
| Transesophageal Echocardiology Measured Left Ventricular End Diastolic Area As Guide for Fluid Therapy in Major Oncosurgeries LVEDA cm2 guided intraoperative fluid in TEE /Study Group, CVP guided intraoperative fluid in CVP / Control group - Fluid Therapy DURING SURGERY | Not applicable | Completed | Rajiv Gandhi Cancer Institute & Research Center, India | 60 | 2019-01-06 | 2025-01-22 |
| A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE) Rituximab, CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone), CVP (cyclophosphamide, vincristine, prednisone) - Non-Hodgkin's Lymphoma | Phase 3 | Completed | Genentech, Inc. | 451 | 2008-07-01 | 2017-05-15 |
| Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab. - Lymphoma, Non-Hodgkin | Phase 2 | Completed | GlaxoSmithKline | 30 | 2000-02-01 | 2017-01-11 |
Lymphoma, Non-Hodgkin (2) · Acute Kidney Injury (1) · Hyperemia (1) · Lymphoma, Follicular (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Genentech, Inc. (1) · GlaxoSmithKline (1) · Nanjing First Hospital, Nanjing Medical University (1) · Rajiv Gandhi Cancer Institute & Research Center, India (1)
China (2) · India (1)
Anita Kulkarni, M.D. (1) · Anita Kulkarni, MD (1) · Deborah Hurst, M.D. (1) · Ya-li Ge (1)